Terms: = Pancreatic cancer AND NRG1, ENSG00000157168, 3084, SMDF, NDF, HRGA, HRG1, HGL, GGF2, GGF, ARIA AND Prognosis
6 results:
1. pancreatic cancer biomarkers: A pathway to advance in personalized treatment selection.
Brozos-Vázquez E; Toledano-Fonseca M; Costa-Fraga N; García-Ortiz MV; Díaz-Lagares Á; Rodríguez-Ariza A; Aranda E; López-López R
Cancer Treat Rev; 2024 Apr; 125():102719. PubMed ID: 38490088
[TBL] [Abstract] [Full Text] [Related]
2. PARPis and Other Novel, Targeted Therapeutics in pancreatic Adenocarcinoma.
Chapin WJ; Reiss KA
Hematol Oncol Clin North Am; 2022 Oct; 36(5):1019-1032. PubMed ID: 36154785
[TBL] [Abstract] [Full Text] [Related]
3. [Ductal adenocarcinoma of the pancreas: subtypes and molecular pathology].
Schlitter AM; Konukiewitz B; Kasajima A; Reichert M; Klöppel G
Pathologe; 2021 Sep; 42(5):464-471. PubMed ID: 34402977
[TBL] [Abstract] [Full Text] [Related]
4. Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma.
Qian Y; Gong Y; Fan Z; Luo G; Huang Q; Deng S; Cheng H; Jin K; Ni Q; Yu X; Liu C
J Hematol Oncol; 2020 Oct; 13(1):130. PubMed ID: 33008426
[TBL] [Abstract] [Full Text] [Related]
5. prognosis Relevance of Serum Cytokines in pancreatic cancer.
Torres C; Linares A; Alejandre MJ; Palomino-Morales RJ; Caba O; Prados J; Aránega A; Delgado JR; Irigoyen A; Martínez-Galán J; Ortuño FM; Rojas I; Perales S
Biomed Res Int; 2015; 2015():518284. PubMed ID: 26346854
[TBL] [Abstract] [Full Text] [Related]
6. Identifying patients with undetected pancreatic cancer in primary care: an independent and external validation of Qcancer(®) (Pancreas).
Collins GS; Altman DG
Br J Gen Pract; 2013 Sep; 63(614):e636-42. PubMed ID: 23998844
[TBL] [Abstract] [Full Text] [Related]